Proteomics analysis of A375 human malignant melanoma cells in response to arbutin treatment

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1794, Issue 2, 2009, Pages 159-167

  Nawarak, Jiraporn ^a   Huang Liu, Rosa ^b   Kao, Shao Hsuan ^b   Liao, Hsien Hua ^b   Sinchaikul, Supachok ^a   Chen, Shui Tein ^a,c   Cheng, Sun Long ^b  

^a INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

A375 cells; Arbutin; Cancer; Malignant melanoma; Proteomics

Indexed keywords

ALPHA ENOLASE; ARBUTIN; CELL PROTEIN; ENDOPLASMIN PRECURSOR; INOSINATE DEHYDROGENASE; PEROXIREDOXIN 1; PROTEIN 14 3 3; PROTEIN 14 3 3 GAMMA; PROTEIN ENPL; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VIMENTIN; VOLTAGE DEPENDENT ANION CHANNEL 1;

AMINO ACID SEQUENCE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CARCINOGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MELANOMA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS; ARBUTIN; CELL LINE, TUMOR; DOWN-REGULATION; HUMANS; MELANOMA; METABOLIC NETWORKS AND PATHWAYS; PROTEIN BINDING; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY; UP-REGULATION;

EID: 58149194767     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2008.09.023     Document Type: Article

References (58)

1. Chakraborty A.K., Funasaka Y., Komoto M., and Ichihashi M. Effect of arbutin on melanogenic proteins in human melanocytes. Pigment Cell Res. 11 (1998) 206-212
2. Maeda K., and Fukuda M. Arbutin: mechanism of its depigmenting action in human melanocyte culture. J. Pharmacol. Exp. Ther. 276 (1996) 765-769
3. Nakajima M., Shinoda I., Fukuwatari Y., and Hayasawa H. Arbutin increases the pigmentation of cultured human melanocytes through mechanisms other than the induction of tyrosinase activity. Pigment Cell Res. 11 (1998) 12-17
4. Dooley T.P. Topical skin depigmentation agents: current products and discovery of novel inhibitors of melanogenesis. J. Dematol. Treat. 7 (1997) 188-200
5. Hermanns J.F., Petit L., Martalo O., Pierard-Franchimont C., Cauwenbergh G., and Pierard G.E. Unraveling the patterns of subclinical pheomelanin-enriched facial hyperpigmentation: effect of depigmenting agents. Dermatology 201 (2000) 118-122
6. Frenk E. Treatment of melasma with depigmenting agents. Melasma: New Approaches to Treatment (1995), Martin Dunitz Ltd., London 9-15
7. Blaut M., Braune A., Wunderlich S., Sauer P., Schneider H., and Glatt H. Mutagenicity of arbutin in mammalian cells after activation by human intestinal bacteria. Food Chem. Toxicol. 44 (2006) 1940-1947
8. Cheng S.L., Liu R.H., Sheu J.N., Chen S.T., Sinchaikul S., and Tsay G.J. Toxicogenomics of A375 human malignant melanoma cells treated with arbutin. J. Biomed. Sci. 14 (2007) 87-105
9. Eswarakumar V.P., Lax I., and Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 16 (2005) 139-149
10. L'Hote C.G., and Knowles M.A. Cell responses to FGFR3 signaling: growth, differentiation and apoptosis. Exp. Cell. Res. 304 (2005) 417-431
11. Janosch P., Kieser A., Eulitz M., Lovric J., Sauer G., Reichert M., Gounari F., Büscher D., Baccarini M., Mischak H., and Kolch W. The Raf-1 kinase associates with vimentin kinases and regulates the structure of vimentin filaments. FASEB J. 14 (2000) 2008-2021
12. Ivaska J., Vuoriluoto K., Huovinen T., Izawa I., Inagaki M., and Parker P.J. PKC-mediated phosphorylation of vimentin controls integrin recycling and motility. EMBO J. 24 (2005) 3834-3845
13. Reilein A.R., Tint I.S., Peunova N.I., Enikolopov G.N., and Gelfand V.I. Regulation of organelle movement in melanophores by protein kinase A (PKA), protein kinase C (PKC), and protein phosphatase 2A (PP2A). J. Cell Biol. 142 (1998) 803-813
14. Szalay J., Bruno P., Bhati R., Adjodha J., Schueler D., Summerville V., and Vazeos R. Associations of PKC isoforms with the cytoskeleton of B16F10 melanoma cells. J. Histochem. Cytochem. 49 (2001) 49-65
15. Nakanishi K., Maruyama M., Shibata T., and Morishima N. Identification of a caspase-9 substrate and detection of its cleavage in programmed cell death during mouse development. J. Biol. Chem. 276 (2001) 41237-41244
16. Byun Y., Chen F., Chang R., Trivedi M., Green K.J., and Cryns V.L. Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis. Cell Death Differ. 8 (2001) 443-450
17. Müller K., Dulku S., Hardwick S.J., Skepper J.N., and Mitchinson M.J. Changes in vimentin in human macrophages during apoptosis induced by oxidised low density lipoprotein. Atherosclerosis 156 (2001) 133-144
18. Yang X., Wang J., Liu C., Grizzle W.E., Yu S., Zhang S., Barnes S., Koopman W.J., Mountz J.D., Kimberly R.P., and Zhang H.G. Cleavage of p53-vimentin complex enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of rheumatoid arthritis synovial fibroblasts; cell injury, repair, aging and apoptosis. Am. J. Pathol. 167 (2005) 705-719
19. McInroy L., and Maatta A. Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion. Biochem. Biophys. Res. Comm. 360 (2007) 109-114
20. Benitez-King G. PKC activation by melatonin modulates vimentin intermediate filament organization in N1E-115 cells. J. Pineal. Res. 29 (2000) 8-14
21. Lindquist S., and Craig E.A. The heat shock proteins. Anuu. Rev. Genet. 22 (1998) 631-637
22. Beere H.M. "The stress of dying": the role of heat shock proteins in the regulation of apoptosis. J. Cell Sci. 117 (2004) 2641-2651
23. Pratt W.B., and Toft D.O. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp. Biol. Med. 228 (2003) 111-133
24. Ciocca D.R., and Calderwood S.K. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10 (2005) 86-103
25. Aitken A. 14-3-3 and its possible role in coordinating multiple signalling pathways. Trends Cell Biol. 6 (1996) 341-347
26. Tzivion G., and Avruch J. 14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation. J. Biol. Chem. 277 (2002) 3061-3064
27. Li S., Janosch P., Tanji M., Rosenfeld G.C., Waymire J.C., Mischak H., Kolch W., and Sedivy J.M. Regulation of Raf-1 kinase activity by the 14-3-3 family of proteins. EMBO 14 (1995) 685-696
28. Halazonetics T.D., Davis L.J., and Kandil A.N. Wild type p53 adopts a "mutant"-like conformation when bound to DNA. EMBO J. 12 (1993) 1021-1028
29. Waterman J.L.F., Shenk J.L., and Halozonetis T.D. The dihedral symmetry of the p53 tetramerization domain mandates a conformational switch upon DNA binding. EMBO J. 14 (1995) 512-519
30. Kroemer G., Zamzami N., and Susin S.A. Mitochondrial control of apoptosis. Immunol. Today 18 (1997) 44-51
31. Crompton M., Virji S., Doyle V., Johnson N., and Ward J.M. The mitochondrial permeability transition pore. Biochem. Soc. Symp. 66 (1999) 167-179
32. Halestrap A.P., Doran E., Gillespie J.P., and O'Toole A. Mitochondria and cell death. Biochem. Soc. Trans. 28 (2000) 170-177
33. Di-Lisa F., Gambassi G., Spurgeon H., and Hansford R.G. Intramitochondrial free calcium in cardiac myocytes in relation to dehydrogenase activation. Cardiovasc. Res. 2 (1993) 1840-1844
34. Berridge M.J., Bootman M.D., and Lipp P. Calcium - a life and death signal. Nature 395 (1998) 645-648
35. Zoratti M., and Szabo I. The mitochondrial permeability transition. Biochim. Biophys. Acta 1241 (1995) 139-176
36. Bernardi P. Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol. Rev. 79 (1999) 1127-1155
37. Cesura A.M., Pinard E., Schubenel R., Goetschy V., Friedlein A., Langen H., Polcic P., Forte M.A., Bernardi P., and Kemp J.A. The voltage-dependent anion channel is the target for a new class of inhibitors of the mitochondrial permeability transition pore. J. Biol. Chem. 278 (2003) 49812-49818
38. Shoshan-Barmatz V., and Gincel D. The voltage-dependent anion channel: characterization, modulation, and role in mitochondrial function in cell life and death. Cell Biochem. Biophys. 39 (2003) 279-292
39. Shimizu S., Narita M., and Tsujimoto Y. Bcl-2 family of proteins target mitochondrial channel VDAC to regulate apoptogenic cytochrome c release. Nature 399 (1999) 483-487
40. Shimizu S., Ide T., Yanagida T., and Tujimoto Y. Electrophysiological study of a novel large pore formed by Bax and VDAC, which is permeable to cytochrome c. J. Biol. Chem. 275 (2000) 12321-12325
41. Shimizu S., Konishi A., Kodama T., and Tsujimoto Y. BH4 domain of anti-apoptotic Bcl-2 family members closes VDAC, and inhibits apoptotic mitochondrial changes and cell death. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 3100-3105
42. Zaid H., Abu-Hamad S., Israelson A., Nathan I., and Shoshan-Barmatz V. The voltage-dependent anion channel-1 modulates apoptotic cell death. Cell Death Differ. 12 (2005) 751-760
43. Macip S., Igarashi M., Berggren P., Yu J., Lee S.W., and Aaronson S.A. Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol. Cell. Biol. 23 (2003) 8576-8585
44. Chang G.C., Liu K.J., Hsieh C.L., Hu T.S., Charoenfuprasert S., Liu H.K., Luh K.T., Hsu L.H., Wu C.W., Ting C.C., Chen C.Y., Chen K.C., Yang T.Y., Chou T.Y., Wang W.H., Whang-Peng J., and Shih N.Y. Identification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes. Clin. Cancer Res. 12 (2006) 5746-5754
45. Johnson T.M., Yu Z.X., Ferans V.J., Lowenstein R.A., and Finkel T. Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 11848-11852
46. Li P.F., Dietz R., and von Harsdorf R. P53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J. 18 (1993) 6027-6036
47. Polyak K., Xia Y., Zweier J.L., Kinzler K.W., and Vogelstein B. A model for p53-induced apoptosis. Nature 389 (1997) 300-305
48. Butterfield L.H., Merino A., Golub S.H., and Shau H. From cytoprotection to tumor suppression: the multifactorial role of peroxiredoxins. Antioxid. Redox. Signal. 1 (1999) 385-401
49. Kim Y.J., Ahn J.Y., Liang P., Ip C., Zhang Y., and Park Y.M. Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation: implication to tumor biology. Cancer Res. 67 (2007) 546-554
50. Chen M.F., Chen W.C., Wu C.T., Lin P.Y., Shau H., Liao S.K., Yang C.T., and Lee K.D. p53 status is a major determinant of effects of decreasing peroxiredoxin 1 expression on tumor growth and response of lung cancer cells to treatment. Int. J. Rad. Oncol. Biol. Phys. 66 (2006) 1461-1472
51. Cohen M.B., and Sadee W. Contributions of the depletions of guanine and adenine nucleotides to the toxicity of purine starvation in the mouse T lymphoma cell line. Cancer Res. 43 (1983) 1587-1591
52. Collart F.R., Chubb C.B., Mirkin B.L., and Huberman E. Increased inosine-5′-phosphate dehydrogenase gene expression in solid tumor tissues and tumor cell lines. Cancer Res. 52 (1992) 5826-5828
53. Jackson R.C., Weber G., and Morris H.P. IMP dehydrogenase, an enzyme linked with proliferation and malignancy. Nature 256 (1975) 331-333
54. Natsumeda Y., Ohno S., Kawasaki H., Konno Y., Weber G., and Suzuki K. Two distinct cDNAs for human IMP dehydrogenase. J. Biol. Chem. 265 (1990) 5292-5295
55. Zimmermann A.G., Gu J.J., Laliberté J., and Mitchell B.S. Inosine-5′-monophosphate dehydrogenase: regulation of expression and role in cellular proliferation and T lymphocyte activation. Prog. Nucl. Acid Res. Mol. Biol. 61 (1998) 181-209
56. Pimkin M., and Markham G.D. The CBS subdomain of inosine 5′-monophosphate dehydrogenase regulates purine nucleotide turnover. Mol. Microbiol. 68 (2008) 342-359
57. Kichina J., Green A., and Rauth S. Tumor suppressor p53 down-regulates tissue-specific expression of tyrosinase gene in human melanoma cell lines. Pigment Cell Res. 9 (1996) 85-91
58. Nylander K., Bourdon J.C., Bray S.E., Gibbs N.K., Kay R., Hart I., and Hall P.A. Transcriptional activation of tyrosinase and TRP-1 by p53 links UV irradiation to the protective tanning response. J. Pathol. 190 (2000) 39-46